Follow
Ian Boys
Ian Boys
Postdoctoral Fellow, University of Utah
Verified email at genetics.utah.edu
Title
Cited by
Cited by
Year
LY6E impairs coronavirus fusion and confers immune control of viral disease
S Pfaender, KB Mar, E Michailidis, A Kratzel, IN Boys, P V’kovski, W Fan, ...
Nature microbiology 5 (11), 1330-1339, 2020
1982020
A CRISPR screen identifies IFI6 as an ER-resident interferon effector that blocks flavivirus replication
RB Richardson, MB Ohlson, JL Eitson, A Kumar, MB McDougal, IN Boys, ...
Nature microbiology 3 (11), 1214-1223, 2018
152*2018
LY6E mediates an evolutionarily conserved enhancement of virus infection by targeting a late entry step
KB Mar, NR Rinkenberger, IN Boys, JL Eitson, MB McDougal, ...
Nature communications 9 (1), 3603, 2018
1082018
RTP4 is a potent IFN-inducible anti-flavivirus effector engaged in a host-virus arms race in bats and other mammals
IN Boys, E Xu, KB Mar, C Pamela, JL Eitson, B Moon, JW Schoggins
Cell host & microbe 28 (5), 712-723. e9, 2020
382020
Identification of atovaquone, ouabain and mebendazole as FDA approved drugs Tar-geting SARS-CoV-2 (version 4)
A Farag, P Wang, IN Boys, JL Eitson, MB Ohlson, W Fan, MB McDougal, ...
34*2020
Shiftless inhibits flavivirus replication in vitro and is neuroprotective in a mouse model of Zika virus pathogenesis
NW Hanners, KB Mar, IN Boys, JL Eitson, PC De La Cruz-Rivera, ...
Proceedings of the National Academy of Sciences 118 (49), e2111266118, 2021
252021
Evolution of the interferon response: lessons from ISGs of diverse mammals
MB McDougal, IN Boys, P De La Cruz-Rivera, JW Schoggins
Current opinion in virology 53, 101202, 2022
182022
Structural homology screens reveal host-derived poxvirus protein families impacting inflammasome activity
IN Boys, AG Johnson, MR Quinlan, PJ Kranzusch, NC Elde
Cell reports 42 (8), 2023
7*2023
FDA approved drugs with antiviral activity against SARS-CoV-2: From structure-based repurposing to host-specific mechanisms
MS Ahmed, AB Farag, IN Boys, P Wang, I Menendez-Montes, ...
Biomedicine & Pharmacotherapy 162, 114614, 2023
62023
Identification of atovaquone and mebendazole as repurposed drugs with antiviral activity against SARS-CoV-2
MS Ahmed, AB Farag, P Wang, IN Boys, I Menendez-Montes, N Uyen
Cambridge Open Engage: Cambridge, UK, 2021
52021
Functional-genomic analysis reveals intraspecies diversification of antiviral receptor transporter proteins in Xenopus laevis
IN Boys, KB Mar, JW Schoggins
PLoS genetics 17 (5), e1009578, 2021
22021
Development of a mutant aerosolized ACE2 that neutralizes SARS-CoV-2 in vivo
DL Kober, MC Caballero Van Dyke, JL Eitson, IN Boys, MB McDougal, ...
Mbio 15 (6), e00768-24, 2024
12024
When viruses do not go gentle into that good night
IN Boys, NC Elde
Cell Host & Microbe 30 (11), 1499-1500, 2022
12022
Evolution of STAT2 resistance to flavivirus NS5 occurred multiple times despite genetic constraints
EC Veit, MS Salim, MJ Jung, RB Richardson, IN Boys, M Quinlan, ...
Nature Communications 15 (1), 5426, 2024
2024
IFIT1 is rapidly evolving and exhibits disparate antiviral activities across 11 mammalian orders
MB McDougal, AM De Maria, E Nakahara, IN Boys, JW Schoggins
bioRxiv, 2024.05. 13.593954, 2024
2024
Identification of Receptor Transporting Proteins As Conserved Antiviral Effectors in Vertebrates
IN Boys
2021
Interferon-stimulated gene LY6E enhances entry of diverse RNA viruses
K Mar, I Boys, J Eitson, M McDougal, J Schoggins
CYTOKINE 100, 77-78, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–17